October 25, 2016

A number of enzymes (proteins that aid in biological reactions) have been pin-pointed in having a profound effect on the genetic building and neurological pathways associated closely with Autism and Autism Spectrum Disorders.

The family of proteins, called topoisomerases are predominantly responsible for winding and unwinding DNA during the process of replication, when new cells are formed and copied and can have  profound effects on the genetic machinery behind brain development and potentially lead to autism spectrum disorder (ASD).

The outcome was announced on August 28 by scientists in residence at University of North Carolina School of Medicine who believe that this is a significant breakthrough in understanding how Autism develops during gestation. Autism Daily Newscast included a brief summary of the findings in our weekly research review which can be found here.

Senior study author Mark Zylka, PhD said:

“This could point to an environmental component to autism. A temporary exposure to a topoisomerase inhibitor in utero has the potential to have a long-lasting effect on the brain, by affecting critical periods of brain development. “

A small change in the structure of these enzymes could lead to an array of genetic mutations and changes in neurological pathways which alter the chemistry and biology of the brain, and thought behavioural patterns in an individual.

Zylka and his colleagues stumbled upon the discovery quite by accident, while looking at a protein used commonly in chemotherapy treatment –  Topotecan They noticed that the drug tended to interfere with the proper functioning of genes that were exceptionally long  and composed of many DNA base pairs. The group then made the serendipitous connection that many autism-linked genes are extremely long.

There are over 300 genes linked to Autism, but using the chemotherapy protein suppressed over 50 of them, which is means that  suppressing that many genes across the board — even to a small extent — means a person who is exposed to a topoisomerase inhibitor during brain development could experience neurological effects equivalent to those seen in a person who gets ASD because of a single faulty gene.

About the author 

Shân Ellis

Shân Ellis, is a qualified journalist with five years experience of writing features, blogging and working on a regional newspaper. Prior to working as a journalist, she was a ghost writer for top publishers and was closely involved in the editing and development of book series. Shân has a degree in the sciences, and 5 A levels. She lives in the UK and is the mother of an autistic child.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

RELATED POSTS

December 24, 2020

From YouTube The United States Senate unanimously passed

December 18, 2020

Everyone experiences anxiety at one time or another,

December 3, 2020

Autism Daily Newscast recently ran a feature on

November 21, 2020

CC BY by nick step Kristin Cavallari, star

November 19, 2020

Autism is a complex disorder with many facets.

November 16, 2020

Issues surrounding safety, bullying, abuse and wandering have

November 13, 2020

Connor Sparrowhawk from YouTube by Sarah Ryan Oxford,

>